179 related articles for article (PubMed ID: 33498972)
1. Evidence for Establishing the Clinical Breakpoint of Cefquinome against Haemophilus Parasuis in China.
Mi K; Sun D; Li M; Hao H; Zhou K; Liu Z; Yuan Z; Huang L
Pathogens; 2021 Jan; 10(2):. PubMed ID: 33498972
[No Abstract] [Full Text] [Related]
2. In vitro dynamic pharmacokinetic/pharmacodynamic(PK/PD) modeling and PK/PD cutoff of cefquinome against Haemophilus parasuis.
Xiao X; Sun J; Chen Y; Huang RJ; Huang T; Qiao GG; Zhou YF; Liu YH
BMC Vet Res; 2015 Feb; 11():33. PubMed ID: 25889187
[TBL] [Abstract][Full Text] [Related]
3. Epidemiological and PK/PD cutoff values determination and PK/PD-based dose assessment of gamithromycin against Haemophilus parasuis in piglets.
Zhou YF; Bu MX; Liu P; Sun J; Liu YH; Liao XP
BMC Vet Res; 2020 Mar; 16(1):81. PubMed ID: 32138735
[TBL] [Abstract][Full Text] [Related]
4. Exploration of Clinical Breakpoint of Danofloxacin for
Xu Z; Huang A; Luo X; Zhang P; Huang L; Wang X; Mi K; Fang S; Huang X; Li J; Yuan Z; Hao H
Antibiotics (Basel); 2021 Jul; 10(7):. PubMed ID: 34356730
[No Abstract] [Full Text] [Related]
5. Determination of Susceptibility Breakpoint for Cefquinome against
Mi K; Li M; Sun L; Hou Y; Zhou K; Hao H; Pan Y; Liu Z; Xie C; Huang L
Antibiotics (Basel); 2021 Aug; 10(8):. PubMed ID: 34439008
[No Abstract] [Full Text] [Related]
6. In vitro Dynamic Pharmacokinetic/Pharmacodynamic (PK/PD) study and COPD of Marbofloxacin against Haemophilus parasuis.
Sun J; Xiao X; Huang RJ; Yang T; Chen Y; Fang X; Huang T; Zhou YF; Liu YH
BMC Vet Res; 2015 Dec; 11():293. PubMed ID: 26626889
[TBL] [Abstract][Full Text] [Related]
7. The Epidemiologic and Pharmacodynamic Cutoff Values of Tilmicosin against Haemophilus parasuis.
Zhang P; Hao H; Li J; Ahmad I; Cheng G; Chen D; Tao Y; Huang L; Wang Y; Dai M; Liu Z; Yuan Z
Front Microbiol; 2016; 7():385. PubMed ID: 27047487
[TBL] [Abstract][Full Text] [Related]
8. Comparison of PK/PD Targets and Cutoff Values for Danofloxacin Against
Zhou YF; Sun Z; Wang RL; Li JG; Niu CY; Li XA; Feng YY; Sun J; Liu YH; Liao XP
Front Vet Sci; 2022; 9():811967. PubMed ID: 35187143
[TBL] [Abstract][Full Text] [Related]
9. Optimal Regimens and Cutoff Evaluation of Tildipirosin Against
Lei Z; Liu Q; Qi Y; Yang B; Khaliq H; Xiong J; Moku GK; Ahmed S; Li K; Zhang H; Zhang W; Cao J; He Q
Front Pharmacol; 2018; 9():765. PubMed ID: 30093860
[No Abstract] [Full Text] [Related]
10. Integration of pharmacokinetic-pharmacodynamic for dose optimization of doxycycline against Haemophilus parasuis in pigs.
Zhang L; Li Y; Wang Y; Sajid A; Ahmed S; Li X
J Vet Pharmacol Ther; 2018 Oct; 41(5):706-718. PubMed ID: 29696661
[TBL] [Abstract][Full Text] [Related]
11. The pharmacokinetic-pharmacodynamic modeling and cut-off values of tildipirosin against
Lei Z; Liu Q; Yang B; Ahmed S; Cao J; He Q
Oncotarget; 2018 Jan; 9(2):1673-1690. PubMed ID: 29416722
[TBL] [Abstract][Full Text] [Related]
12. PK/PD integration and pharmacodynamic cutoff of cefquinome against cow mastitis due to Escherichia coli.
Xiao X; Chen X; Yan K; Jiang L; Li R; Liu Y; Wang M; Wang Z
J Vet Pharmacol Ther; 2022 Jan; 45(1):83-91. PubMed ID: 34469000
[TBL] [Abstract][Full Text] [Related]
13. Optimal regimens based on PK/PD cutoff evaluation of ceftiofur against Actinobacillus pleuropneumoniae in swine.
Sun D; Mi K; Hao H; Xie S; Chen D; Huang L
BMC Vet Res; 2020 Sep; 16(1):366. PubMed ID: 32993661
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics, bioavailability and dose assessment of Cefquinome against Escherichia coli in black swans (Cygnus atratus).
Zhao DH; Wang XF; Wang Q; Li LD
BMC Vet Res; 2017 Jul; 13(1):226. PubMed ID: 28754112
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic/pharmacodynamic (PK/PD) evaluation of tulathromycin against Haemophilus parasuis in an experimental neutropenic guinea pig model.
Zhao Y; Guo LL; Fang B; Liu B
PLoS One; 2018; 13(12):e0209177. PubMed ID: 30596709
[TBL] [Abstract][Full Text] [Related]
16. Optimizing tylosin dosage for co-infection of
Lee EB; Abbas MA; Park J; Tassew DD; Park SC
Front Pharmacol; 2023; 14():1258403. PubMed ID: 37808183
[TBL] [Abstract][Full Text] [Related]
17.
Jiang LJ; Xiao X; Yan KX; Deng T; Wang ZQ
Front Vet Sci; 2022; 9():837882. PubMed ID: 35350432
[TBL] [Abstract][Full Text] [Related]
18. PK/PD modeling of Ceftiofur Sodium against Haemophilus parasuis infection in pigs.
Li XD; Chi SQ; Wu LY; Liu C; Sun T; Hong J; Chen X; Chen XG; Wang GS; Yu DJ
BMC Vet Res; 2019 Aug; 15(1):272. PubMed ID: 31370843
[TBL] [Abstract][Full Text] [Related]
19. Optimal Regimens and Clinical Breakpoint of Avilamycin Against
Huang A; Luo X; Xu Z; Huang L; Wang X; Xie S; Pan Y; Fang S; Liu Z; Yuan Z; Hao H
Front Pharmacol; 2022; 13():769539. PubMed ID: 35281904
[No Abstract] [Full Text] [Related]
20. Kill Rate and Evaluation of
Zhang L; Xie H; Wang H; Ding H; Zhang G; Hu J
Front Vet Sci; 2021; 8():751957. PubMed ID: 34966804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
